SCHEMBL4775698

SCHEMBL4775698

[c]1nc(-c2ccccn2)c(-c2ncccc2-c2ccccn2)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.41
KDM4E B2RXH2 5/20 0.38
LMNA P02545 3/20 0.38
CCR1 P32246 2/20 0.38
CCR5 P51681 2/20 0.38
CCR8 P51685 2/20 0.38
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38
METAP1 P53582 1/20 0.38
BLM P54132 1/20 0.38
HIF1A Q16665 1/20 0.38
DOHH Q9BU89 1/20 0.38
P4HTM Q9NXG6 1/20 0.38
LRRK2 Q5S007 1/20 0.36
HTR7 P34969 1/20 0.36
NPY5R Q15761 1/20 0.36
ULK1 O75385 1/20 0.35
CDK7 P50613 1/20 0.35
CDK5 Q00535 1/20 0.35
PRKCE Q02156 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10326320 0.84 KDM4E (0.46) KDM4ELMNACCR1CCR5CCR8
SCHEMBL11166709 0.80 NPY5R (0.45) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30031 0.78 KDM4E (0.56) IDO1KDM4ELMNACCR1CCR5
Hydrochloric Acid SCHEMBL932365 0.76 KDM4E (0.54) IDO1KDM4ELMNACCR1CCR5
SCHEMBL933820 0.76 KDM4E (0.54) IDO1KDM4ELMNACCR1CCR5
SCHEMBL78140 0.76 KDM4E (0.54) IDO1KDM4ELMNACCR1CCR5
SCHEMBL16241819 0.76 KDM4E (0.54) IDO1KDM4ELMNACCR1CCR5
SCHEMBL319436 0.76 KDM4E (0.54) IDO1KDM4ELMNACCR1CCR5
SCHEMBL1652383 0.76 KDM4E (0.54) IDO1KDM4ELMNACCR1CCR5
SCHEMBL16241838 0.76 KDM4E (0.54) IDO1KDM4ELMNACCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US disclosed
EP-1713778-A1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LIMITED (GB) 2006-10-25 EP disclosed
WO-2005058837-A1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LIMITED (GB) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 IDO1 310/4885KDM4E 488/4885LMNA 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.